Clinical trial
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed…
NCT00042991 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00042991 |
|---|---|
| Title | Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas |
| Official title | Phase I/II Trial of Gefitinib and Radiation in Pediatric Patients Newly Diagnosed With Brain Stem Tumors or Incompletely Resected Supratentorial Malignant Gliomas With Phase II Limited to Brain Stem Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Untreated Childhood Anaplastic Astrocytoma, Untreated Childhood Anaplastic Oligodendroglioma, Untreated Childhood Brain Stem Glioma, Untreated Childhood Giant Cell Glioblastoma, Untreated Childhood Glioblastoma, Untreated Childhood Gliomatosis Cerebri, Untreated Childhood Gliosarcoma, Untreated Childhood Oligodendroglioma |
| Intervention type | Drug, Other, Radiation |
| Interventions | gefitinib, radiation therapy, pharmacological study, laboratory biomarker analysis |
| Enrollment | 69 |
| Start date | Jul 1, 2002 |
| Primary completion | Feb 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | May 28, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: